phase readout
saveNCT05821855: A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: AbbVie. Phase: PHASE4. Conditions: Open-angle Glaucoma, OAG
view source ↗
comments(0)
5-min edit window · permanent after that